Molecular typing is based on molecular genetic tests and is not nevertheless routinely obtainable. Molecular subtypes and immunohistochemical surrogate markers of your tumors (HR, HER2, triple unfavorable) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and